Ordering Information

Ordering REZZAYO

Everything you need to know to order REZZAYO with ease and confidence

REZZAYO (rezafungin for injection)

200 mg per vial

NDC 70842-240-01
How supplied REZZAYO (rezafungin for injection) is supplied as a sterile white to pale yellow solid (cake or powder) in a single-dose 20 mL Type I glass vial with a stopper, an aluminum seal, and a blue polypropylene flip-off cap. The vial stopper is not made with natural rubber latex.
Packaging configuration One single-dose vial of REZZAYO 200 mg
(NDC 70842-240-01)
Storage REZZAYO vials should be stored at 20°C to 25°C (68°F to 77°F). Brief exposure to 15°C to 30°C (59°F to 86°F) permitted.
How to order REZZAYO is available through the following distributors.
Practice type
Distributor Phone Web
Hospitals
Cardinal Specialty Pharmaceutical Distribution (CAH SPD) 855-855-0708 pdlogin.cardinalhealth.com
ASD Healthcare (ABSG) 800-746-6273 asdhealthcare.com
Clinics, infusion centers, physician offices, or home infusions
Metro Medical (Cardinal Health) 800-768-2002 metromedicalorder.com
Besse Medical 800-543-2111 besse.com
Oncology practices
Cardinal SPD 877-453-3972 pdlogin.cardinalhealth.com
Oncology Supply 800-633-7555 oncologysupply.com

Download the REZZAYO Order Form

Download Form

Medical Information

For medical inquiries or to report an adverse event, other safety-related information, or product complaints, please contact Medical Information.

1-844-MED-MLNT (1-844-633-6568)

Explore REZZAYO support and resources to enroll your patients today

View Support and Resources

INDICATION AND USAGE

REZZAYO (rezafungin for injection) is an echinocandin antifungal indicated in patients 18 years of age or older who have limited or no alternative options for the treatment of candidemia and invasive candidiasis. Approval of this indication is based on limited clinical safety and efficacy data.

Limitations of Use

REZZAYO has not been studied in patients with endocarditis, osteomyelitis, and meningitis due to Candida.

IMPORTANT SAFETY INFORMATION

Contraindications

REZZAYO is contraindicated in patients with known hypersensitivity to rezafungin or other echinocandins.

Warnings and Precautions

  • Infusion-related Reactions: REZZAYO may cause infusion-related reactions, including flushing, sensation of warmth, urticaria, nausea, or chest tightness. If these reactions occur, slow or pause the infusion.
  • Photosensitivity: REZZAYO may cause photosensitivity. Advise patients to use protection from sun exposure and other sources of UV radiation.
  • Hepatic Adverse Reactions: Abnormalities in liver tests have been seen in clinical trial patients treated with REZZAYO. Monitor patients who develop abnormal liver tests and evaluate patients for their risk/benefit of continuing REZZAYO therapy.

Adverse Reactions

Most common adverse reactions (incidence ≥ 5%) are hypokalemia, pyrexia, diarrhea, anemia, vomiting, nausea, hypomagnesemia, abdominal pain, constipation, and hypophosphatemia.

Please see full Prescribing Information for REZZAYO (rezafungin for injection).

See more

INDICATION AND USAGE

REZZAYO (rezafungin for injection) is an echinocandin antifungal indicated in patients 18 years of age or older who have limited or no alternative options for the

IMPORTANT SAFETY INFORMATION

Contraindications

REZZAYO is contraindicated in patients with known hypersensitivity to rezafungin or other echinocandins.